Clinical Trials Directory

Trials / Completed

CompletedNCT05040750

Correlation Between Cardiac Markers and Severity of COVID-19

Correlation Between Cardiac Markers and Severity of COVID-19 in Egyptian Population

Status
Completed
Phase
Study type
Observational
Enrollment
207 (actual)
Sponsor
Ain Shams University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

By July 9, 2020, the global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection had resulted in over 11.8 million confirmed cases and over 545000 deaths. Patients with a history of cardiovascular disease are especially vulnerable and have a bad prognosis. According to the findings, cardiac injury manifested by cardiac biomarker elevation is detected in a significant number of COVID-19 patients and is linked to poor outcomes and mortality. However, it is unclear how effective cardiac biomarkers are in COVID-19 prognosis and how to use these indicators.

Detailed description

The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has led to \>11.8 million confirmed cases with \>545000 deaths worldwide by July 9, 2020 Patients with preexisting cardiovascular conditions are particularly at risk and have poor prognosis data suggest that cardiac injury, manifested by cardiac biomarker elevation, is detected in a sizable of COVID-19 patients and is associated with adverse outcomes and increased mortality. However, how useful cardiac biomarkers are in COVID-19 prognosis and how to utilize these markers have not been well defined The study will include all moderate to severe COVID 19 patients admitted to ICU. Both genders within the age group 18-60 years were included. The primary outcome is the relation between cardiac markers and mortality rate in critically ill COVID 19 patients The secondary outcome is the relationship between cardiac and inflammatory and coagulation markers

Conditions

Interventions

TypeNameDescription
OTHERlaboratory investigationobserve the relation between cardiac markers and mortality rate in critically ill COVID 19 patients

Timeline

Start date
2021-09-01
Primary completion
2023-07-30
Completion
2023-07-30
First posted
2021-09-10
Last updated
2024-10-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05040750. Inclusion in this directory is not an endorsement.